person
Emiliano T.
- Country
- Italy
- Department
- Oncology
Research Overview
assignment
51
Clinical Trials ·
- Pumitamig and Combination Therapy Versus Bevacizumab and Combination Therapy in Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Efficacy and Safety of PF-08634404 and Combination Therapy Versus Bevacizumab and Combination Therapy in Treatment-Naïve Participants With Metastatic Colorectal Cancer
- Phase III Randomized Trial of AZD0901 with Capecitabine ± Rilvegostomig in First‑Line Claudin‑18.2‑Positive HER2‑Negative Advanced Gastric, GEJ or Esophageal Adenocarcinoma
location_city
1
Research Sites
Data & Insights
medical_services
Primary Speciality
Main therapeutic area
handshake
Return Partnerships
Recurring site collaborations
348
Sites with multiple studies
Has run more than one trial at 348 of 667 partner sites.
Specializations
Colorectal Cancer Research
Leading multiple investigations in metastatic colorectal cancer treatment strategies, with particular focus on targeted therapies and immunotherapy approaches.
- RAS/BRAF mutation-specific treatments
- HER2-positive colorectal cancer interventions
- Circulating tumor DNA-guided therapies
- Novel drug combinations for recurrent disease
Gastrointestinal Oncology
Conducting innovative research in gastric cancer and hepatocellular carcinoma, exploring new therapeutic combinations.
- Advanced gastric and gastroesophageal junction cancers
- Pancreatic adenocarcinoma treatments
- Biliary tract cancer interventions
- Liver cancer immunotherapy approaches
Precision Medicine Applications
Pioneering research in biomarker-driven treatment strategies and personalized medicine approaches across multiple cancer types.
- Molecular profiling for treatment selection
- Liquid biopsy applications
- Targeted therapy combinations
- Immunotherapy response prediction
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.